Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

“There are instances where a brand name product may be ... to patients with certain types of asthma,” said Ganio. “It’s not a ...

A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy. Investigator sites are essential for ...

After many trips to the doctor's office, five-year-old Burton Hayes's asthma was finally under control with a ... In addition ...

For millions of asthma sufferers worldwide, the distinctive puff of an inhaler represents a lifeline, providing instant relief from constricted airways. Dr Juma Bwika, a pulmonologist at Aga Khan ...

Topline results were announced from a phase 3b trial evaluating albuterol/budesonide metered dose inhaler in ... (ICS) asthma rescue therapy approved under the brand name Airsupra ...

A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy. The phase 3b BATURA study showed Airsupra ...

Those using a rescue inhaler during an asthma attack, especially, may want a propellant to help push the medicine into their airways. This is why GSK Plc is focusing on lowering the emissions of ...